Position in LENZ
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$190,137
-$116,471 QoQ
Shares Held
20,780
+8.4% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LENZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DNB Asset Management AS holds $242,159,625 across 67 Biotechnology names. LENZ ranks #57 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
1,221,387 | $68,996,151 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
107,311 | $47,918,653 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
43,381 | $33,517,895 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
90,088 | $15,226,673 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
181,085 | $10,530,092 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
31,427 | $10,398,251 | |
| 7 | INSM |
INSMED Inc
|
53,170 | $8,694,358 | |
| 8 | IRON |
Disc Medicine, Inc.
|
96,755 | $6,186,514 |
All Filings in LENZ
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $190,137 | 20,780 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $306,608 | 19,163 | Shares | Other | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||